Regeneron Says Early-Stage Results Positive for REGN1979 in Lymphoma

Date : 06/14/2019 @ 11:56AM
Source : Dow Jones News
Stock : Regeneron Pharmaceuticals Inc (REGN)
Quote : 344.28  0.0 (0.00%) @ 12:00AM

Regeneron Says Early-Stage Results Positive for REGN1979 in Lymphoma

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart

6 Months : From May 2019 to Nov 2019

Click Here for more Regeneron Pharmaceuticals Charts.

By Michael Dabaie


Regeneron Pharmaceuticals Inc. (REGN) said results were positive from early-stage data for REGN1979 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

The company said there was a 93% overall response and 71% complete response rates in follicular lymphoma grades 1 to 3a treated with REGN1979 5 mg to 320 mg.

There was a 57% overall response rate in diffuse large B-cell lymphoma treated with REGN1979 80 mg to 160 mg, all of which were complete responses, including two complete responses in four patients whose disease had progressed after CAR-T treatment, the company said.

"We are very encouraged by the continued high response rates observed with REGN1979 in both relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma, cancers with typically poor outcomes," said Israel Lowy, head of clinical and translational sciences, oncology at Regeneron.


Write to Michael Dabaie at


(END) Dow Jones Newswires

June 14, 2019 07:41 ET (11:41 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.